JP2011528354A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011528354A5 JP2011528354A5 JP2011518807A JP2011518807A JP2011528354A5 JP 2011528354 A5 JP2011528354 A5 JP 2011528354A5 JP 2011518807 A JP2011518807 A JP 2011518807A JP 2011518807 A JP2011518807 A JP 2011518807A JP 2011528354 A5 JP2011528354 A5 JP 2011528354A5
- Authority
- JP
- Japan
- Prior art keywords
- piperidinyl
- cyclopropyl
- dihydro
- oxo
- methoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims 12
- 150000003839 salts Chemical class 0.000 claims 9
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims 6
- 235000011090 malic acid Nutrition 0.000 claims 6
- 239000008194 pharmaceutical composition Substances 0.000 claims 6
- AVPQPGFLVZTJOR-NEPJUHHUSA-N 7-[(3s,5r)-3-amino-5-methylpiperidin-1-yl]-1-cyclopropyl-8-methoxy-4-oxoquinoline-3-carboxylic acid Chemical compound COC1=C(N2C[C@@H](N)C[C@@H](C)C2)C=CC(C(C(C(O)=O)=C2)=O)=C1N2C1CC1 AVPQPGFLVZTJOR-NEPJUHHUSA-N 0.000 claims 5
- 241000191967 Staphylococcus aureus Species 0.000 claims 5
- 229940049920 malate Drugs 0.000 claims 5
- 241000193998 Streptococcus pneumoniae Species 0.000 claims 4
- 229940099690 malic acid Drugs 0.000 claims 4
- 239000001630 malic acid Substances 0.000 claims 4
- 208000035143 Bacterial infection Diseases 0.000 claims 3
- RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 claims 3
- 241000191963 Staphylococcus epidermidis Species 0.000 claims 3
- 208000022362 bacterial infectious disease Diseases 0.000 claims 3
- 229960003085 meticillin Drugs 0.000 claims 3
- 229940031000 streptococcus pneumoniae Drugs 0.000 claims 3
- 208000015181 infectious disease Diseases 0.000 claims 2
- AVPQPGFLVZTJOR-RYUDHWBXSA-N nemonoxacin Chemical compound COC1=C(N2C[C@@H](N)C[C@H](C)C2)C=CC(C(C(C(O)=O)=C2)=O)=C1N2C1CC1 AVPQPGFLVZTJOR-RYUDHWBXSA-N 0.000 claims 2
- LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical compound C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 claims 2
- BJEPYKJPYRNKOW-UWTATZPHSA-N (R)-malic acid Chemical compound OC(=O)[C@H](O)CC(O)=O BJEPYKJPYRNKOW-UWTATZPHSA-N 0.000 claims 1
- 241000194032 Enterococcus faecalis Species 0.000 claims 1
- 241000588724 Escherichia coli Species 0.000 claims 1
- 241000606768 Haemophilus influenzae Species 0.000 claims 1
- 241000588652 Neisseria gonorrhoeae Species 0.000 claims 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 claims 1
- 241000191940 Staphylococcus Species 0.000 claims 1
- 201000005010 Streptococcus pneumonia Diseases 0.000 claims 1
- 108010059993 Vancomycin Proteins 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940032049 enterococcus faecalis Drugs 0.000 claims 1
- 229940047650 haemophilus influenzae Drugs 0.000 claims 1
- 229940116298 l- malic acid Drugs 0.000 claims 1
- 229960003165 vancomycin Drugs 0.000 claims 1
- MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 claims 1
- MYPYJXKWCTUITO-LYRMYLQWSA-O vancomycin(1+) Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C([O-])=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)[NH2+]C)[C@H]1C[C@](C)([NH3+])[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-O 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8080908P | 2008-07-15 | 2008-07-15 | |
| US61/080,809 | 2008-07-15 | ||
| PCT/US2009/050241 WO2010009014A2 (en) | 2008-07-15 | 2009-07-10 | Antibiotic drug |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011528354A JP2011528354A (ja) | 2011-11-17 |
| JP2011528354A5 true JP2011528354A5 (enExample) | 2012-08-09 |
Family
ID=41550976
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011518807A Withdrawn JP2011528354A (ja) | 2008-07-15 | 2009-07-10 | 抗生物質 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20120157492A1 (enExample) |
| JP (1) | JP2011528354A (enExample) |
| KR (1) | KR20110050623A (enExample) |
| CN (1) | CN101628911B (enExample) |
| TW (1) | TW201008567A (enExample) |
| WO (1) | WO2010009014A2 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0709220A2 (pt) | 2006-03-28 | 2011-07-12 | Procter & Gamble | processo de acoplamento para preparo de intermediários de quinolona |
| WO2010002415A1 (en) * | 2008-07-01 | 2010-01-07 | Taigen Biotechnology Co., Ltd. | Treatment of antibiotic-resistant bacteria infection |
| CN103145615B (zh) * | 2013-03-20 | 2015-07-29 | 浙江医药股份有限公司 | 一种奈诺沙星螯合物的后处理方法 |
| CA2920791C (en) | 2013-10-14 | 2021-11-16 | Eisai R&D Management Co., Ltd. | Selectively substituted quinoline compounds |
| CN106336371A (zh) * | 2016-08-16 | 2017-01-18 | 成都百事兴科技实业有限公司 | 叔丁氧羰基‑l‑焦谷氨酸甲酯的合成方法 |
| CN113640416A (zh) * | 2021-08-12 | 2021-11-12 | 海南海神同洲制药有限公司 | 盐酸左氧氟沙星片的含量测定方法 |
| CN116785271A (zh) * | 2023-07-13 | 2023-09-22 | 河南农业大学 | 苹果酸及其衍生物在制备金属-β-内酰胺酶增敏剂中的应用、组合物和其应用 |
| CN118852222B (zh) * | 2024-06-27 | 2025-09-05 | 南京桦冠生物技术有限公司 | 一种奈诺沙星中间体及其制备方法和应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1015445B1 (en) * | 1997-09-15 | 2009-02-25 | The Procter & Gamble Company | Antimicrobial quinolones, their compositions and uses |
| JP4876165B2 (ja) * | 2006-03-28 | 2012-02-15 | ザ プロクター アンド ギャンブル カンパニー | キノロン中間体を調製するための水素化物還元法 |
-
2009
- 2009-07-10 US US12/500,952 patent/US20120157492A1/en not_active Abandoned
- 2009-07-10 WO PCT/US2009/050241 patent/WO2010009014A2/en not_active Ceased
- 2009-07-10 KR KR1020117001200A patent/KR20110050623A/ko not_active Withdrawn
- 2009-07-10 JP JP2011518807A patent/JP2011528354A/ja not_active Withdrawn
- 2009-07-14 TW TW098123739A patent/TW201008567A/zh unknown
- 2009-07-14 CN CN2009101604652A patent/CN101628911B/zh active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011528354A5 (enExample) | ||
| JP2013047268A5 (enExample) | ||
| JP2012506871A5 (enExample) | ||
| JP2011530534A5 (enExample) | ||
| JP2015504921A5 (enExample) | ||
| JP2012513467A5 (enExample) | ||
| JP2013508269A5 (enExample) | ||
| JP2013253094A5 (enExample) | ||
| IL272888B2 (en) | Novel uses of piperidinyl-indole derivatives | |
| NZ702796A (en) | Immunogenic anti-inflammatory compositions | |
| HRP20130928T1 (hr) | C7-fluor supstituirani spojevi tetraciklina | |
| RU2018114480A (ru) | Соли и твердые формы монобактамного антибиотика | |
| WO2015089073A3 (en) | Compositions and methods for phagocyte delivery of anti-staphylococcal agents | |
| JP2012506870A5 (enExample) | ||
| JP2013539751A5 (enExample) | ||
| JP2009503024A5 (enExample) | ||
| HRP20191295T1 (hr) | Kristalne soli amida (4s,4as,5ar,12as)-4-dimetilamino-3,10,12,12a-tetrahidroksi-7-[(metoksi(metil)amino)-metil]-1,11-diokso-1,4,4a,5,5a,6,11,12a-oktahidro-naftacen-2-karboksilne kiseline i postupci uporabe istih | |
| JP2017519730A5 (enExample) | ||
| WO2014022382A3 (en) | Antibacterial protein kinase inhibitors | |
| JP2012512164A5 (enExample) | ||
| JP2014520077A5 (enExample) | ||
| RU2013137752A (ru) | Твердые формы ингибитора гиразы (r)-1-этил-3-[6-фтор-5[2-(1-гидрокси-1-метил-этил) пиримидин-5-ил]-7-(тетрагидрофуран-2-ил)-1н-бензимидазол-2-ил] мочевины | |
| JP2016534121A5 (enExample) | ||
| JP2011526887A5 (enExample) | ||
| JP2010507576A5 (enExample) |